{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:32:20Z","timestamp":1760131940599},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.clinthera.2007.08.001","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T14:45:34Z","timestamp":1191509134000},"page":"1591-1606","source":"Crossref","is-referenced-by-count":27,"title":["Transdermal Buprenorphine Patches Applied in a 4-Day Regimen Versus a 3-Day Regimen: A Single-Site, Phase III, Randomized, Open-Label, Crossover Comparison"],"prefix":"10.1016","volume":"29","author":[{"given":"Rudolf","family":"Likar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Korak-Leiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Kager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Sittl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.08.001_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","article-title":"Buprenorphine: A review of its pharmacological properties and therapeutic efficacy","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2007.08.001_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.clinthera.2007.08.001_bib3","first-page":"517","article-title":"The effects of morphine- and nalorphine-like drugs in the nonde-pendent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.clinthera.2007.08.001_bib4","series-title":"Evidence Based Medicine in Practice","first-page":"1","article-title":"Buprenorphine: A review","author":"Budd","year":"2002"},{"key":"10.1016\/j.clinthera.2007.08.001_bib5","first-page":"3","article-title":"Buprenorphine: New pharmacological aspects","volume":"133","author":"Cowan","year":"2003","journal-title":"Int J Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2007.08.001_bib6","first-page":"62","article-title":"Buprenorphine [in German]","volume":"143","author":"Menzel","year":"2003","journal-title":"Deutsche Apotheker Zeitu ng."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2007.08.001_bib7","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/s100670200031","article-title":"Buprenorphine in a transdermal therapeutic system\u2014a new option","volume":"21","author":"Bohme","year":"2002","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.clinthera.2007.08.001_bib8","first-page":"9","article-title":"Buprenorphine and the transdermal system: The ideal match in pain management","volume":"133","author":"Budd","year":"2003","journal-title":"Int J Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2007.08.001_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.me.39.020188.001253","article-title":"Transdermal delivery of drugs","volume":"39","author":"Brown","year":"1988","journal-title":"Annu Rev Med."},{"key":"10.1016\/j.clinthera.2007.08.001_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1359-6446(04)03180-0","article-title":"The transdermal revolution","volume":"9","author":"Thomas","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clinthera.2007.08.001_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1015944018555","article-title":"Transdermal delivery of narcotic analgesics: Comparative permeabilities of narcotic analgesics through human cadaver skin","volume":"6","author":"Roy","year":"1989","journal-title":"Pharm Res."},{"key":"10.1016\/j.clinthera.2007.08.001_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jps.2600830204","article-title":"Transdermal delivery of buprenorphine through cadaver skin","volume":"83","author":"Roy","year":"1994","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.clinthera.2007.08.001_bib13","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2165\/00003495-200363190-00003","article-title":"Transdermal buprenorphine","volume":"63","author":"Evans","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2007.08.001_bib14","first-page":"317","article-title":"Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain [in German]","volume":"153","author":"Likar","year":"2003","journal-title":"Wien Med Wochenschr."},{"key":"10.1016\/j.clinthera.2007.08.001_bib15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1185\/030079905X53315","article-title":"Transdermal buprenorphine in clinical practice-a post-marketing surveillance study in 13,179 patients","volume":"21","author":"Griessinger","year":"2005","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2007.08.001_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.clinthera.2006.06.012","article-title":"Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials","volume":"28","author":"Likar","year":"2006","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2007.08.001_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clinthera.2005.04.007","article-title":"Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: A multicenter, open-label, uncontrolled, prospective, observational clinical study","volume":"27","author":"Muriel","year":"2005","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2007.08.001_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/14737175.5.3.315","article-title":"Transdermal buprenorphine in the treatment of chronic pain","volume":"5","author":"Sittl","year":"2005","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.clinthera.2007.08.001_bib19","series-title":"World Medical Association Declaration of Helsinki: Recommendations guiding medical doctors in biomedical research involving human subjects","year":"2007"},{"key":"10.1016\/j.clinthera.2007.08.001_bib21","series-title":"International Statistical Classification of Diseases and Related Healtk Problems","year":"2004"},{"key":"10.1016\/j.clinthera.2007.08.001_bib22","series-title":"The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC\/DDD)","year":"2007"},{"key":"10.1016\/j.clinthera.2007.08.001_bib23","first-page":"61","article-title":"Current data on the exploration and the evaluation of clinical pain [in French]","volume":"186","author":"Boureau","year":"1992","journal-title":"C R Seances Soc Biol Fil"},{"key":"10.1016\/j.clinthera.2007.08.001_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0885-3924(01)00409-2","article-title":"Pain measurement tools and methods in clinical research in palliative care: Recommendations of an Expert Working Group of the European Association of Palliative Care","volume":"23","author":"Caraceni","year":"2002","journal-title":"J Pain Symptom Manage."},{"key":"10.1016\/j.clinthera.2007.08.001_bib25","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.clinthera.2007.08.001_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care."},{"key":"10.1016\/j.clinthera.2007.08.001_bib27","series-title":"MedDRA\u2014The Medical Dictionary for Regulatory Activities","year":"2007"},{"key":"10.1016\/j.clinthera.2007.08.001_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1163\/156856903321579334","article-title":"Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study","volume":"15","author":"Bohme","year":"2003","journal-title":"Pain Clinic"},{"key":"10.1016\/j.clinthera.2007.08.001_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2007.08.001_bib30","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.clinthera.2004.11.008","article-title":"Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study","volume":"26","author":"Sorge","year":"2004","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2007.08.001_bib31","series-title":"SF-36\u00ae Health Survey & \u201cSF\u201d Bibliography: Third Edition (1988\u20132000)","author":"Turner-Bowker","year":"2002"},{"key":"10.1016\/j.clinthera.2007.08.001_bib32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0190-9622(90)70113-V","article-title":"Adverse dermatologic reactions to transdermal drug delivery systems","volume":"22","author":"Hogan","year":"1990","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clinthera.2007.08.001_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00128071-200001060-00004","article-title":"Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management","volume":"1","author":"Murphy","year":"2000","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.clinthera.2007.08.001_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2310\/6620.2006.05051","article-title":"Cutaneous reactions to transdermal therapeutic systems","volume":"17","author":"Musel","year":"2006","journal-title":"Dermatitis"},{"key":"10.1016\/j.clinthera.2007.08.001_bib35","first-page":"19","article-title":"Buprenorphine TDS: Use in daily practice, benefits for patients","volume":"133","author":"Radbruch","year":"2003","journal-title":"IntJ Clin Pract Suppl."},{"key":"10.1016\/j.clinthera.2007.08.001_bib36","series-title":"Buprenorphine matrix patch (Transtec): Taking control of chronic pain [scientific monograph]","year":"2002"},{"key":"10.1016\/j.clinthera.2007.08.001_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1191\/026921601678320296","article-title":"Transdermal fentanyl for the management of cancer pain: A survey of 1005 patients","volume":"15","author":"Radbruch","year":"2001","journal-title":"Palliat Med."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T17:22:53Z","timestamp":1546536173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0149291807002366"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.08.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}